These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 21395978)
21. MicroRNA regulation of cardiac conduction and arrhythmias. Kim GH Transl Res; 2013 May; 161(5):381-92. PubMed ID: 23274306 [TBL] [Abstract][Full Text] [Related]
22. Dicing the Disease with Dicer: The Implications of Dicer Ribonuclease in Human Pathologies. Theotoki EI; Pantazopoulou VI; Georgiou S; Kakoulidis P; Filippa V; Stravopodis DJ; Anastasiadou E Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33007856 [TBL] [Abstract][Full Text] [Related]
23. miR-1 mediated suppression of Sorcin regulates myocardial contractility through modulation of Ca2+ signaling. Ali R; Huang Y; Maher SE; Kim RW; Giordano FJ; Tellides G; Geirsson A J Mol Cell Cardiol; 2012 May; 52(5):1027-37. PubMed ID: 22326846 [TBL] [Abstract][Full Text] [Related]
24. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs. de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159 [TBL] [Abstract][Full Text] [Related]
25. MicroRNAs in heart failure: from biomarker to target for therapy. Vegter EL; van der Meer P; de Windt LJ; Pinto YM; Voors AA Eur J Heart Fail; 2016 May; 18(5):457-68. PubMed ID: 26869172 [TBL] [Abstract][Full Text] [Related]
26. Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease. Notari M; Pulecio J; Raya Á Biomed Res Int; 2015; 2015():105620. PubMed ID: 26221581 [TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in heart failure: new targets in disease management. Elzenaar I; Pinto YM; van Oort RJ Clin Pharmacol Ther; 2013 Oct; 94(4):480-9. PubMed ID: 23852395 [TBL] [Abstract][Full Text] [Related]
28. Distinct requirements of microRNAs in NK cell activation, survival, and function. Bezman NA; Cedars E; Steiner DF; Blelloch R; Hesslein DG; Lanier LL J Immunol; 2010 Oct; 185(7):3835-46. PubMed ID: 20805417 [TBL] [Abstract][Full Text] [Related]
29. MicroRNAs: new players in heart failure. Oliveira-Carvalho V; da Silva MM; Guimarães GV; Bacal F; Bocchi EA Mol Biol Rep; 2013 Mar; 40(3):2663-70. PubMed ID: 23242657 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA involvement in immune activation during heart failure. van de Vrie M; Heymans S; Schroen B Cardiovasc Drugs Ther; 2011 Apr; 25(2):161-70. PubMed ID: 21503626 [TBL] [Abstract][Full Text] [Related]
33. Noncoding RNAs in Cardiac Hypertrophy. Li Y; Liang Y; Zhu Y; Zhang Y; Bei Y J Cardiovasc Transl Res; 2018 Dec; 11(6):439-449. PubMed ID: 30171598 [TBL] [Abstract][Full Text] [Related]
34. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases. Hang P; Guo J; Sun C; Du Z Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular importance of the microRNA-23/27/24 family. Bang C; Fiedler J; Thum T Microcirculation; 2012 Apr; 19(3):208-14. PubMed ID: 22136461 [TBL] [Abstract][Full Text] [Related]
36. Novel insights into the pervasive role of M(3) muscarinic receptor in cardiac diseases. Hang P; Zhao J; Qi J; Wang Y; Wu J; Du Z Curr Drug Targets; 2013 Mar; 14(3):372-7. PubMed ID: 23317008 [TBL] [Abstract][Full Text] [Related]
37. Target mRNA-Driven Biogenesis of Cognate MicroRNAs In Vitro. Bose M; Bhattacharyya SN Methods Mol Biol; 2018; 1733():27-39. PubMed ID: 29435920 [TBL] [Abstract][Full Text] [Related]